AI heart-tracing alert to find atrial fibrillation early
Tests an AI alert on heart tracings to guide rhythm monitoring for atrial fibrillation.
Plain-language title generated from the registry record
Registry title: Leveraging AI-ECG Technology for Early Notification and Tracking of AF Development
Key facts
- Where
- Taipei, TaiwanSee the site
Where in Taiwan
- Tri-Service General HospitalTaipei, TaiwanTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- National Defense Medical Center, Taiwan
- Trial code
- NCT06847932
- Record updated
- 19 November 2025
- Original description
Our study aimed to use an AF-predict AI-ECG alert system to help physicians identify patients who need to wear a continuous cardiac rhythm monitor for new diagnoses of atrial fibrillation (AF), atrial flutter (AFL), or atrial arrhythmia with high AF risk, including premature atrial complexes (PAC) ≥ 500/24hr, burst PACs > 20 beats, non-sustained AF/AFL.Read full original descriptionShow less
Leveraging AI-ECG Technology for Early Notification and Tracking of AF Development: a Randomized Control Trial
Our study aimed to use an AF-predict AI-ECG alert system to help physicians identify patients who need to wear a continuous cardiac rhythm monitor for new diagnoses of atrial fibrillation (AF), atrial flutter (AFL), or atrial arrhythmia with high AF risk, including premature atrial complexes (PAC) ≥ 500/24hr, burst PACs > 20 beats, non-sustained AF/AFL.
Inclusion: Patients in the inpatient department or the outpatient department; Patients need to have at least one electrocardiogram within one year.
Exclusion: History of received rhythm control medications for atrial arrhythmia, including Class I and Class III antiarrhythmic drugs; History of atrial fibrillation/atrial flutter catheter ablation; Patients with cardiac implantable electronic devices; Diagnosis of atrial fibrillation/atrial flutter; Any documented electrocardiogram showed atrial fibrillation/atrial flutter and pacing rhythm; Any reasons indicate for anti-coagulant agents, including vitamin K antagonist and non-vitamin K antagonist oral anticoagulant.